Combined blockade of early and late activated atrial potassium currents suppresses atrial fibrillation in a pig model of obstructive apnea

被引:36
作者
Linz, Dominik [1 ,2 ]
Schotten, Ulrich [2 ]
Neuberger, Hans-Ruprecht [1 ]
Boehm, Michael [1 ]
Wirth, Klaus [3 ]
机构
[1] Univ Klinikum Saarlandes, Innere Med Klin 3, D-66421 Homburg, Germany
[2] Cardiovasc Res Inst Maastricht, Maastricht, Netherlands
[3] Sanofi Aventis Deutsch GmbH, Res & Dev, Aging Disabil CVC Origin, Frankfurt, Germany
关键词
Obstructive sleep apnea; Atrial fibrillation; Antiarrhythmia agents; Electrophysiology; Potassium-channel; CLASS-III DRUGS; SLEEP-APNEA; IN-VIVO; ANTIARRHYTHMIC-DRUGS; HEART-FAILURE; EFFICACY; AMIODARONE; MECHANISMS; RECEPTOR; CELLS;
D O I
10.1016/j.hrthm.2011.07.018
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND Negative tracheal pressure (NTP) during tracheal obstruction in obstructive apnea increases vagal tone and causes pronounced shortening of the atrial effective refractory period (AERP), thereby perpetuating atrial fibrillation (AF). The role of different atrial potassium channels under those conditions has not been investigated. OBJECTIVE The purpose of this study was to evaluate the atrial effects of blockade of the late activated potassium current (I-Kr) by sotalol, of blockade of the early activated potassium currents (I-Kur/I-to) by AVE0118, and of the multichannel blocker amiodarone during tracheal occlusions with applied NTP. METHODS Twenty-one pigs were anesthetized, and an endotracheal tube was placed to apply NTP (up to -100 mbar) comparable to clinically observed obstructive sleep apnea for 2 minutes. Right AERP and AF inducibility were measured transvenously by a monophasic action potential recording and stimulation catheter. RESULTS Tracheal occlusion with applied NTP caused pronounced AERP shortening. AF was inducible during all NTP maneuvers. Blockade of I-Kr by sotalol, blockade of I-Kur/I-to by AVE0118, and amiodarone did not affect NTP-induced AERP shortening, although they prolonged the AERP during normal breathing. Atropine given after amiodarone completely inhibited NTP-induced AERP shortening. The combined blockade of I-Kr and I-Kur/I-to by sotalol plus AVE0118, however, attenuated NTP-induced AERP shortening and AF inducibility independent of the order of administration. CONCLUSION The atrial proarrhythmic effect of NTP simulating obstructive apneas is difficult to inhibit by class III antiarrhythmic drugs. Neither amiodarone nor blockade of I-Kr or I-Kur/I-to attenuated NTP-induced AERP shortening. However, the combined blockade of I-Kur/I-to and I-Kr suppressed NTP-induced AERP shortening.
引用
收藏
页码:1933 / 1939
页数:7
相关论文
共 32 条
[1]   Cardioversion of persistent atrial fibrillation by a combination of atrial specific and non-specific class III drugs in the goat [J].
Blaauw, Y. ;
Schotten, U. ;
van Hunnik, A. ;
Neuberger, H. R. ;
Allessie, M. A. .
CARDIOVASCULAR RESEARCH, 2007, 75 (01) :89-98
[2]   Early class III drugs for the treatment of atrial fibrillation -: Efficacy and atrial selectivity of AVE0118 in remodeled atria of the goat [J].
Blaauw, Y ;
Gögelein, H ;
Tieleman, RG ;
van Hunnik, A ;
Schotten, U ;
Allessie, MA .
CIRCULATION, 2004, 110 (13) :1717-1724
[3]   Ionic targets for drug therapy and atrial fibrillation-induced electrical remodeling: insights from a mathematical model [J].
Courtemanche, M ;
Ramirez, RJ ;
Nattel, S .
CARDIOVASCULAR RESEARCH, 1999, 42 (02) :477-489
[4]   Consequences of atrial electrical remodeling for the anti-arrhythmic action of class IC and class III drugs [J].
Duytschaever, A ;
Blaauw, Y ;
Allessie, A .
CARDIOVASCULAR RESEARCH, 2005, 67 (01) :69-76
[5]   Implications of obstructive sleep apnea for atrial fibrillation and sudden cardiac death [J].
Gami, Apoor S. ;
Somers, Virend K. .
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2008, 19 (09) :997-1003
[6]   Obstructive sleep apnea, obesity, and the risk of incident atrial fibrillation [J].
Gami, Apoor S. ;
Hodge, Dave O. ;
Herges, Regina M. ;
Olson, Eric J. ;
Nykodym, Jiri ;
Kara, Tomas ;
Somers, Virend K. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 49 (05) :565-571
[7]   Association of atrial fibrillation and obstructive sleep apnea [J].
Gami, AS ;
Pressman, G ;
Caples, SM ;
Kanagala, R ;
Gard, JJ ;
Davison, DE ;
Malouf, JF ;
Ammash, NM ;
Friedman, PA ;
Somers, VK .
CIRCULATION, 2004, 110 (04) :364-367
[8]   In vivo and in vitro characterization of the novel antiarrhythmic agent SSR149744C - Electrophysiological, anti-adrenergic, and anti-angiotensin II effects [J].
Gautier, P ;
Guillemare, E ;
Djandjighian, L ;
Marion, A ;
Planchenault, J ;
Bernhart, C ;
Herbert, JM ;
Nisato, D .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2004, 44 (02) :244-257
[9]   Effects of the atrial antiarrhythmic drug AVE0118 on cardiac ion channels [J].
Gögelein, H ;
Brendell, J ;
Steinmeyer, K ;
Strübing, C ;
Picard, N ;
Rampe, D ;
Kopp, K ;
Busch, AE ;
Bleich, M .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2004, 370 (03) :183-192
[10]   Inhibitory effects of dronedarone on muscarinic K+ current in guinea pig atrial cells [J].
Guillemare, E ;
Marion, A ;
Nisato, D ;
Gautier, P .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2000, 36 (06) :802-805